2 Laparoscopic hysterectomy in endometrial cancer
|
|
- Hilary Lewis
- 8 years ago
- Views:
Transcription
1 Laparoscopic hysterectomy in endometrial cancer
2 .1 Total laparoscopic hysterectomy versus abdominal hysterectomy in the treatment of patients with early stage endometrial cancer: A randomized multi center study Claudia B.M. Bijen, Justine M. Briët, Geertruida H. de Bock, Henriette J. Arts, Janneke A. Bergsma-Kadijk, Marian J.E. Mourits BMC Cancer 009 Jan; 9:3
3 Abstract Background: Traditionally standard treatment for patients with early stage endometrial cancer (EC) is total abdominal hysterectomy and bilateral salpingo oophorectomy (TAH+BSO) with or without lymph node dissection through a vertical midline incision. While TAH is an accepted effective treatment, it is highly invasive, visibly scarring and associated with morbidity. An alternative treatment is the same operation by laparoscopy. Though in several studies total laparoscopic hysterectomy (TLH+ BSO) seems a safe and feasible alternative approach in early stage endometrial cancer patients, there are no randomized data available yet. Furthermore, a randomized controlled trial with surgeons trained in laparoscopy is warranted in order to implement this technique in a safe manner. The aim of this study is to compare the treatment related morbidity, cost-effectiveness and quality of life in early stage endometrial cancer patients treated by laparoscopy versus the standard open approach. Methods/Design: A multi centre randomized clinical phase 3 trial, including 5 university hospitals and 15 regional hospitals in the Netherlands. Only gynecologists trained in performing a TLH are allowed to participate. Inclusion criteria: Patients with a clinical stage I endometrioid adenocarcinoma or complex atypical hyperplasia are randomized in a :1 allocation to receive TLH or TAH. The main outcome measure is the rate of major complications, as assessed by an independent clinical review board. In total, 75 patients are required to have 80% power at α-0.05 to detect a significant difference of 15% complication rate. Secondary outcome measures are 1) costs and cost-effectiveness, ) minor complications, and 3) quality of life. All data from this multi center study are reported using case record forms. Data regarding quality of life, pain, body Image, sexuality and additional homecare are assessed with self reported questionnaires. Discussion: A randomized multi center study in early stage endometrial cancer patients with inclusion criteria for patients and surgeons is designed and ongoing. 0
4 Background Endometrial cancer is the third most common cancer in women in Western countries, accounting for 6-9% of their cancers, with a peak incidence at the age of year. Endometrial cancer is a disease of the elderly and 90% of patients are over 50 years of age. The incidence increases in obese women and 70% of the patients have a high body mass index (BMI >5) and 50% have co-morbidity such as diabetes and cardiovascular disease. A total of 75% of the patients are diagnosed with stage I disease. Traditionally standard treatment for patients with early stage endometrial cancer (EC) is total abdominal hysterectomy and bilateral salpingo oophorectomy (TAH+BSO) with or without lymph node dissection through a vertical midline incision. While TAH is an accepted effective treatment, it is highly invasive, visibly scarring and associated with adverse events such as blood loss and wound problems. 1, Morbidity of laparotomy in case of endometrial cancer can be substantial due to frequent obesity and co-morbidity in this patient group and hospital stay is usually at least one week. 1 A good alternative approach for patients with early stage disease is by laparoscopy. Laparoscopy in early stage endometrial cancer is a minimal invasive technique compared to the standard approach by laparotomy. In several retrospective and prospective studies it has been shown that the laparoscopic approach is an effective and safe alternative to the open procedure. Most of these studies show a significant reduction in treatment related morbidity, with shorter hospital stay, less pain and quicker return to activities in daily life with the laparoscopic approach compared to laparotomy The advantages of the laparoscopic approach seem to be even more pronounced in obese and elderly patients due to reduced complications and a shorter hospital stay.,10,11 However, the only randomized controlled trial comparing the laparoscopic approach with the open approach was in benign disease. 1 This study is in a different group of patients (young, healthy) than the study population of the here proposed study i.e. elderly women with endometrial cancer. It is known that complications occur more frequently during the initial learning curve of this procedure and some authors suggest a quantity control (i.e. > 5 TLH procedures) for surgeons before participating in studies. 1 Arguments often mentioned hampering the implementation of level three laparoscopic procedures are the high preoperative costs and the long learning curve. However, despite the fact that peroperative costs are higher for laparoscopy due to expensive disposables, it might be that the overall costs will be finely balanced between both procedures due to reduction of morbidity and shorter hospital stay. 13,14 Although randomized studies on this issue are not available yet, studies in which endometrial cancer patients are treated show similar rates and patterns of recurrence. Patients who underwent a TLH+BSO have similar recurrence rates when compared to TAH+BSO, as reported in a retrospective mono-centre study and in two prospective mono-center studies. 3,6,15 In view of these data we proposed a randomized controlled clinical trial in which total laparoscopic hysterectomy performed by trained surgeons is compared to total abdominal hysterectomy in patients with early stage endometrial cancer. Methods Aims and design The aim of this study is to compare treatment related morbidity, cost-effectiveness and quality of life in early stage 1
5 endometrial cancer treated by laparoscopy (TLH+BSO) or laparotomy (TAH+BSO). We hypothesize that laparoscopy will result in less treatment-related morbidity in patients treated for early stage endometrial cancer in a cost-effective manner. The study will also provide insight on whether the laparoscopic approach will improve quality of life as compared to the standard abdominal approach. The proposed research concerns a multi-center prospective randomized clinical phase 3 trial (including at least 15 centers) comparing major complication rate in patients with early stage endometrial cancer, randomized to surgical treatment by laparotomy (TAH+BSO) or laparoscopy (TLH+BSO). The study is conducted according to the principles of the Declaration of Helsinki and in accordance with the Medical Research Involving Human Subjects Act (WMO). The protocol is registered in the clinical Dutch trial register number NTR81. Eligibility criteria Inclusion criteria patients Early stage endometrial cancer patients (endometrioid adenocarcinoma grade 1 or, clinically stage I disease, negative endocervical curettage), after signed written informed consent, age 18 years and older are eligible for this trial. Exclusion criteria patients Exclusion criteria: other histological types than endometrioid adenocarcinoma of the endometrium, clinically advanced disease (stage II to IV), uterine size larger than conform 10 weeks gestation and cardio pulmonary contra indications for laparoscopy. Patient recruitment and consent Eligible patients are identified and counseled by the gynecological staff of participating hospitals. Before entry into the study the gynecologist explains to potential subjects the aims, methods, reasonably anticipated benefits and potential hazards of the study. Before study entry, on all patients an endocervical curettage is performed to make sure that the patient has clinical stage I disease and the cervix is not involved. Subjects are informed that their participation is voluntary and that they may withdraw consent to participate at any time during the study. In every center an independent medical doctor is available for more detailed information both for patients and colleagues if required. After sufficient information, written informed consent has to be obtained. The consent form must be signed before performance of any study-related activity. Patients who decide not to participate in this study are treated according to standard treatment protocol (TAH+BSO). Patients undergo routine physical examination and blood tests prior to the operation in either treatment arm, which is part of the standard procedure before surgery. Randomization and collection of baseline data The patients to be enrolled in this trial are allocated to the TAH or TLH arm by computer randomization. For randomization, blocks of x patients are created such that balance is enforced within each block, stratified per center. Randomization is :1 for intervention to provide more exposure to data on the new laparoscopic procedure.
6 We also expect a better enrolment in the study if the patients have a twofold chance of being allocated to the laparoscopic group as the reduced morbidity seems to be substantial. At study entry, all women have baseline demographic, past gynecologic and medical history recorded in a case record form (CRF). After randomization, but prior to surgical treatment, patients are asked to fill in a questionnaire, consisting items regarding: quality of life (SF-36, EQ-5D), pain (VAS), Body Image Scale (BIS), sexuality (SAQ) and a questionnaire on additional homecare (Figure.1). At local centers, data collection is the responsibility of the local participating gynecologist and research nurses. The data collected in this study are coded and processed with adequate precautions to ensure patient confidentiality. Interventions In this trial, the standard surgical approach TAH+BSO (Table.1) is compared to the investigative surgical procedure TLH+BSO (Table.). Follow-up Outcomes are assessed pre-operatively, after 6 weeks, and after 3 and 6 months, being the moments of routine control assessments and be registered on a case record form (CRF) by the treating physician and checked by the research nurse (status review) (Figure.1). Costs are assessed by a cost assessment (CRF and patient questionnaire). The doctor registers costs on a CRF related to the use of operation materials (disposables), operating time, duration of hospital stay, and treatment of complications. All adverse events are followed until they have abated, or until a stable situation has been reached. Data regarding quality of life (SF-36, EQ-5D), pain (VAS), Body Image Scale (BIS), sexuality (SAQ) and additional homecare are assessed with help of self reported questionnaires 6 weeks, 3 and 6 months after the operation (Figure.1). Monitoring Pre start monitoring To minimize complications due to inexperience, all inexperienced general gynecologists are trained by a visiting gynecologist with experience in laparoscopy until sufficient laparoscopic skills are reached, before study entry. Only gynecologists who reached sufficient scores ( 8 points) on OSATS in performing two independent TLH procedures are allowed to participate in the study. The study coordinator facilitates centers in order to get approval of the medical ethical committee. As the study is set in a national research consortium, allied research nurses are responsible for collecting data, monitoring of the study and promote the study at the local centers. A kick off meeting is held by the study coordinator in every participating center. During this meeting the content and inclusion procedure of the study is explained. On site monitoring During the study period, frequent contact and assistance of the coordination center is enabled by regular telephone calls and visits to all local centers. Furthermore, every three months newsletters by are sent to the centers in order to inform the gynecologists about study progress and bring new items under their attention. 3
7 Publicity of the study is realized by means of presentations held on national and international congresses. Thereby, the study protocol and other related study documents are available online. [ page.asp?page_id=418]. Case record forms, checked by the research nurse of concerned center and self reported patient questionnaires are send to the Trial Coordination Center (TCC) of the coordinating center. The TCC takes care of entry and validating data of case record forms and importing patient questionnaires. In case of discrepancies or inaccuracies found in the case record forms, queries are sent to the centers in question. Final monitoring will be done by the study coordinator by visiting randomly selected centers and checking a part of the case record forms once again. Study parameters/endpoints Main study parameter/endpoint Our primary endpoint is: major complication rate. The following major complications are registered: injuries of bowel, bladder, ureter, vessel, nerves; thrombo-embolic events (i.e. deep venous thrombosis) or pulmonary embolism; haematoma requiring surgical intervention; hemorrhage requiring transfusion and/or surgical intervention; wound dehiscence requiring surgical intervention or re-admission; wound infections including vaginal vault abscess, requiring surgical intervention and/or prolonged hospital stay and/or readmission and/or treatment; other major complications. The severity of a complication is scored according to the Common Terminology Criteria CTCAE version 3.0. An independent Complication Review Board of three experienced clinicians is asked to assess and judge all recorded complications and differentiate between major and minor complications. This Complication Review Board decides also if the complication is related to the operative procedure, as expressed by the following statements: not related, unlikely related, possibly related, probably related or definitely related. [ cancer.gov/protocoldevelopment/electronic_applications/docs/newadverse_006.pdf] Secondary study parameters/endpoints 1) Cost effectiveness; ) Minor complications. Outcomes are assessed by analyzing the CRF; 3) Quality of life (SF-36 and EQ-5D), sexual functioning (Sexual Activity Questionnaire), Body Image Scale (BIS) and pain (Visual Analogue Scale). Premature termination of the study The study will be terminated prematurely if the disadvantages of participation may be significantly greater than was foreseen in the research proposal. All complications are assessed and recorded by an independent clinical review panel. This panel assesses if the complications occurring in the TLH group do exceed in amount or severity the complications occurring in the standard of care (TAH) group. If so, the study will be terminated. 4
8 Statistical analysis Sample size Sample size estimates are based on the ability of the study to detect changes in the primary outcome measure, rate of major complications. In this study, we choose for an unbalanced randomization ((TLH+BSO):1(TAH+BSO)). Group sample sizes of 161 and 81 achieve 80% power to detect a difference of 0.15 between the null hypothesis that the major complication rate is 5% in both the TAH+BSO and the TLH+BSO group and the alternative hypothesis that we will observe a complication rate of 5% in the TAH+BSO group and of 10% in the TLH+BSO group, using a two-sided Chi-square test with continuity correction and with a significance level of Assuming a drop-out percentage of 10%, 75 patients are needed. The assumptions regarding these expected complication rates are based on the complication rates reported in (retrospective) studies comparing TAH with TLH. In addition, this is supported by the major complication rate of 9.6% that we found during the learning curve in our pilot study. The drop-out percentage of 10% can be expected when patients, after randomization, are unhappy with their allocated treatment and choose to end their participation in the study or due to incomplete or lost data. Descriptive statistics Primary endpoints will be analyzed according to the intention-to-treat principle. Descriptive statistics for QOL (SF- 36, EQ-5D, VAS, BIS, SAQ) and a questionnaire on additional homecare) will be calculated for each randomization group at each assessment. Similarly, descriptive statistics will also be calculated for other outcomes, such as pain scores, and analgesic consumption, etc. Continuous variables will be assessed for normality and equality of variances between groups. Discrete variables (e.g. presence/absence of post-operative infection) will be summarized by frequencies/proportions. For continuous variables, analysis of variance and/or regression will be used, where appropriate. If assumptions for these tests are violated, alternative non-parametric tests will be used. Difference between groups with respect to discrete variables will be evaluated by using chi-squared tests. Economic analysis In the economic evaluation the costs of both interventions will be compared. The economic evaluation will be conducted from a societal perspective including direct medical and direct non-medical costs. Relevant cost components that will be taken into account are costs of the laparotomy and laparoscopy, like costs of operating time and use of disposables. In addition, hospital stay, re-interventions for post-operative morbidity and operationrelated medication will be assessed. In case of conversion from TLH to TAH the costs for both procedures will be added to the costs in the TLH group. Home care, consisting of both professional care as well as informal care will be assessed as well. Because most women are aged 55 and older, productivity losses will not be included in the economic evaluation. Cost components will be valued according to standard Dutch guidelines for economic evaluation (CVZ 004). Actual costs will be estimated for the laparotomy and laparoscopy and informal care will be valued by using shadow prices. 5
9 A case record form will be used to gather medical costs. A patient questionnaire will be used to collect information on additional home care. Since no differences regarding recurrence rate are expected at any time between the two study arms, a time horizon of six months is considered to be sufficient for evaluation of morbidity and costs. As a consequence, discounting will not be applied. A sensitivity analysis will be conducted to estimate the impact of variation of major cost elements. Discussion While the standard abdominal hysterectomy for early stage endometrial cancer is an effective and accepted treatment in patients with early stage endometrial cancer, it is highly invasive and associated with serious adverse events. From retrospective or non-randomized trials can be concluded that laparoscopic hysterectomy seems a safe and feasible treatment especially in patients with early stage endometrial cancer. GOG-LAP, a randomized controlled trial in which the effectiveness of a laparoscopic assisted vaginal hysterectomy with BSO and lymphadenectomy in early stage endometrial cancer is compared to the open procedure, has been completed. A major problem in the GOG-LAP study is that inexperienced gynecologists in laparoscopic surgery are allowed to participate and no quality control for the laparoscopists or the laparoscopic procedure is performed. Recently, a randomized multi center trial comparing the laparoscopic with the open approach in early stage endometrial cancer called the LACE trial, has been started in Australia. These studies however, are not applicable to the European situation, because in these studies patients are mostly treated by a hysterectomy and BSO combined with a pelvic and para aortic lymphadenectomy. In Europe, a lymphadenectomy is not standard treatment for patients with early stage endometrial cancer. Moreover, early stage endometrial cancer patients in our proposed study only undergo a hysterectomy with BSO and most of these procedures are performed in general hospitals by general gynecologists. Therefore, a randomized multi center trial with on-site monitoring containing inclusion criteria for patients as well as for surgeons is designed to provide evidence on short term outcome between laparoscopy and laparotomy in patients with early stage endometrial cancer. 6
10 Table.1 Surgical treatment protocol for a TAH, total abdominal hysterectomy Preoperatively thrombosis prophylaxis is given Preoperative antibiotic is given at least 15 min before skin incision Positioning of the patient in lithotomy position Vertical midline incision Abdominal washing for cytology Bipolar coagulation or sealing of the round ligament, cutting with monopolar scissors Opening of the peritoneum of the bladder and the pelvic sidewall Bipolar coagulation or sealing of the infundibulopelvic ligament, cutting with monopolar scissors Preparation of the bladder off the vagina Skeletting the uterine vessels, coagulation or sealing of the vessels, after identification of the ureter Coagulation or sealing and cutting of the sacrouterine ligaments Taking out the uterus. Closing of the vaginal cuff by abdominal stitching Mass closure of sheath, skin closure Table. Surgical treatment protocol for a TLH, total laparoscopic hysterectomy Preoperatively thrombosis prophylaxis is given Preoperative antibiotic is given at least 15 min before skin incision Positioning of the patient in lithotomy position Insufflation of CO and placing of four troicarts Abdominal washing for cytology Bipolar coagulation or sealing of the round ligament, cutting with monopolar scissors Opening of the peritoneum of the bladder and the pelvic sidewall Bipolar coagulation or sealing of the infundibulopelvic ligament, cutting with monopolar scissors Placing the vaginal tube (the Mc Cartney tube). Preparation of the bladder off the vagina Skeletting the uterine vessels, coagulation or sealing of the vessels, after identification of the ureter Coagulation or sealing and cutting of the sacrouterine ligaments Cutting the vaginal wall on the rim of the vaginal tube. Keeping the ureter in sight Taking out the uterus. Closing of the vaginal cuff by abdominal or vaginal stitching 7
11 Figure.1 Assessment schedule Informed Consent Randomisation :1 TLH + BSO (N=161) TAH + BSO (N=81) Assess complications major costs QOL minor Pre Per Post 6 weeks 3 months 6 months 8
12 References 1. Manolitsas TP, McCartney AJ.Total laparoscopic hysterectomy in the management of endometrial carcinoma. J Am Assoc Gynecol Laparosc 00;9: Obermair A, Manolitsas TP, Leung Y, Hammond IG, McCartney AJ. Total laparoscopic hysterectomy versus total abdominal hysterectomy for obese women with endometrial cancer. Int J Gynecol Cancer 005;15: Obermair A, Manolitsas TP, Leung Y, Hammond IG, McCartney AJ. Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival. Gynecol Oncol 004;9: Eltabbakh GH, Shamonki MI, Moody JM, Garafano LL. Laparoscopy as the primary modality for the treatment of women with endometrial carcinoma. Cancer 001;91: Fram KM: Laparoscopically assisted vaginal hysterectomy versus abdominal hysterectomy in stage I endometrial cancer. Int J Gynecol Cancer 00;1: Malur S, Possover M, Michels W, Schneider A. Laparoscopic-assisted vaginal versus abdominal surgery in patients with endometrial cancer--a prospective randomized trial. Gynecol Oncol 001;80: Marana R, Busacca M, Zupi E, Garcea N, Paparella P, Catalano GF. Laparoscopically assisted vaginal hysterectomy versus total abdominal hysterectomy: a prospective, randomized, multicenter study. Am J Obstet Gynecol 1999;180: Lumsden MA, Twaddle S, Hawthorn R, Traynor I, Gilmore D, Davis J et al. A randomised comparison and economic evaluation of laparoscopic-assisted hysterectomy and abdominal hysterectomy. Br J Obstet Gynaecol 000;107: Spirtos NM, Schlaerth JB, Gross GM, Spirtos TW, Schlaerth AC, Ballon SC. Cost and quality-of-life analyses of surgery for early endometrial cancer: laparotomy versus laparoscopy. Am J Obstet Gynecol 1996;174: Scribner DR, Jr., Walker JL, Johnson GA, McMeekin SD, Gold MA, Mannel RS. Surgical management of early-stage endometrial cancer in the elderly: is laparoscopy feasible? Gynecol Oncol 001;83: Tozzi R, Malur S, Koehler C, Schneider A. Analysis of morbidity in patients with endometrial cancer: is there a commitment to offer laparoscopy? Gynecol Oncol 005;97: Garry R, Fountain J, Brown J, Manca A, Mason S, Sculpher M et al. EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy. Health Technol Assess 004;8: Sculpher M, Manca A, Abbott J, Fountain J, Mason S, Garry R. Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: results from a randomised trial. BMJ 004;38: Ellstrom M, Ferraz-Nunes J, Hahlin M, Olsson JH. A randomized trial with a cost-consequence analysis after laparoscopic and abdominal hysterectomy. Obstet Gynecol 1998;91: Tozzi R, Malur S, Koehler C, Schneider A. Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study. J Minim Invasive Gynecol 005;1:
13 . Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: A prospective randomized study Claudia B.M. Bijen, Geertruida de Bock, Marian J.E. Mourits Gynecol Oncol. 009;113():95
14 With great interest we read the article by Malzoni et al. 1 concerning laparoscopic versus open approach in patients with early-stage endometrial cancer. We would like to make a few comments. It can be concluded from literature that the potential health gain of performing a laparoscopic hysterectomy instead of an abdominal hysterectomy in patients with early stage endometrial cancer is related to morbidity. The gain is expected in lowered major complication rate, shorter hospital stay, less pain and quicker return to activities in daily life. The rate and patterns of recurrence are similar between both procedures in these patients, as reported in several retrospective and prospective studies. Therefore, because morbidity is the most important effect parameter, morbidity rate should be the main outcome parameter in a study concerning laparoscopic versus the open approach. However, Malzoni et al. 1 did not clearly define the outcome parameters of their study. Because neither formal power-analysis nor a statistical testing was performed regarding the difference in number of complications between both arms, we believe that no definitive conclusion on the safety of laparoscopy as compared to laparotomy can be drawn from this study. Malzoni et al. 1 focus their analysis on survival as main outcome, again however, without a power analysis and statistical testing. When it comes to survival we believe that this study design is not suitable to draw conclusions about survival as the study has not enough power. The authors knew this already by clarifying; GOG lap- trial enrolled a sufficient high number of patients to determine a prognostic impact of the surgical management on the prognosis of patients with endometrial cancer. When it comes to morbidity, a multi center randomized trial is currently ongoing in the Netherlands and this study is powered to test a difference in morbidity rate between total laparoscopic hysterectomy and total abdominal hysterectomy in patients with early stage endometrial cancer. 1. Malzoni M, Tinelli R, Cosentino F, Perone C, Rasile M, Iuzzolino D et al. Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: a prospective randomized study. Gynecol Oncol 009;11:
15 .3 Lymphadenectomy in endometrial cancer Marian J.E. Mourits, Claudia B.M. Bijen, Geertruida H. Bock Lancet 009; 373(9670):1169
16 The main finding of the MRC ASTEC trial (Jan 10, p 15) is that there is no evidence of benefit from pelvic lymphadenectomy for patients with endometrial cancer. 1 In this trial, surgery consisted of a total abdominal hysterectomy and bilateral salpingo-oophorectomy with or without pelvic lymphadenectomy by laparotomy. However, surgery was also allowed by laparoscopy provided that the procedure could be accomplished safely and as thoroughly as an open procedure. However, whether laparoscopy for endometrial cancer is associated with a better or worse prognosis than open surgery is not known. Since the primary outcome of the study was whether lymphadenectomy could improve the survival of women with early endometrial cancer when compared with surgery without lymphadenectomy, we are puzzled as to why surgeons were allowed to enter patients who underwent a non-standard surgical procedure. Although the proportion who underwent laparoscopy was similar in both groups (6%), and hence the estimate of the difference between the groups is unlikely to be affected, the absolute figures for survival might be changed either positively or negatively. Total laparoscopic hysterectomy is not a standard surgical procedure in endometrial cancer. Laparoscopy for endometrial cancer can only be considered equivalent to an open surgical procedure when this has been proven by a randomised controlled trial. Since we are still awaiting the results of the GOG-LAP study in early-stage endometrial cancer the first randomised trial powered for survival as a primary outcome this is not the case yet. 1. The writing committee on behalf of the ASTEC study group, Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 009;373:
Total laparoscopic hysterectomy versus abdominal hysterectomy in the. treatment of patients with early stage endometrial cancer:
Total laparoscopic hysterectomy versus abdominal hysterectomy in the treatment of patients with early stage endometrial cancer: A randomized multi center study Claudia B.M. Bijen a, Justine M. Briët a,
More informationCosts and effects of laparoscopy versus laparotomy in women with early endometrial cancer
Costs and effects of laparoscopy versus laparotomy in women with early endometrial cancer Claudia Bijen The word described in this thesis was performed at the Department of Gynecology of the University
More informationLaparoscopy versus Laparotomy for primary surgical management of endometrial cancer
Laparoscopy versus Laparotomy for primary surgical management of endometrial cancer Dr. Maria Anna Sabelli Consultant Gynecologist Milano Italy P.O. Box 20154 Milano Milano 20154 Italy Project submitted
More informationLaparoscopic hysterectomy with or without pelvic. lymphadenectomy or sampling in a high-risk series of
Laparoscopic hysterectomy with or without pelvic lymphadenectomy or sampling in a high-risk series of patients with endometrial cancer Susan F Willis Thomas EJ Ind * Desmond Barton Department of Gynaecological
More informationTotal Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy for Endometrial Cancer: A Meta-analysis
DOI:http://dx.doi.org/0.734/APJCP.203.4.4.255 RESEARCH ARTICLE Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy for Endometrial Cancer: A Meta-analysis Hui-Ling Wang, Yan-Fang Ren *,
More informationINTERVENTIONAL PROCEDURES PROGRAMME
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of radical laparoscopic hysterectomy for early stage cervical cancer Introduction This overview
More informationLaparoscopic treatment of endometrial cancer: feasibility and results
European Journal of Obstetrics & Gynecology and Reproductive Biology 124 (2006) 232 236 www.elsevier.com/locate/ejogrb Laparoscopic treatment of endometrial cancer: feasibility and results Eugenio Volpi,
More informationTotal laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival
Gynecologic Oncology 92 (2004) 789 793 www.elsevier.com/locate/ygyno Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival Andreas Obermair, a,b, * Tom P. Manolitsas,
More informationRole of Robotic Surgery in Obese Women with Endometrial Cancer
Role of Robotic Surgery in Obese Women with Endometrial Cancer Anil Tailor Consultant Gynaecological Oncologist Royal Surrey County Hospital Guildford, Surrey, UK St Peters Hospital Chertsey, Surrey, UK
More informationFacing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery
Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery The Condition: Early Stage Gynecologic Cancer A variety of gynecologic
More informationRadical Hysterectomy for Early Stage Cervical Cancer: Laparoscopy Versus Laparotomy
SCIENTIFIC PAPER Radical Hysterectomy for Early Stage Cervical Cancer: Laparoscopy Versus Laparotomy Sarah E. Taylor, MD, William C. McBee Jr., MD, Scott D. Richard, MD, Robert P. Edwards, MD ABSTRACT
More informationThe Role of Laparoscopy in Endometrial Cancer
The Role of Laparoscopy in Endometrial Cancer Prof. Dr. Tugan BEŞE İstanbul University, Cerrahpaşa Medical Faculty Gynecologic Oncology Department Surgical staging in Endometrial Cancer Laparoscopic surgery
More informationHow To Perform Da Vinci Surgery
Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery The Condition: Early Stage Gynecologic Cancer A variety of gynecologic
More informationDA VINCI ROBOTIC HYSTERECTOMY
DA VINCI ROBOTIC HYSTERECTOMY Until recently, surgery for most gynecologic conditions was performed using a large abdominal incision. This is because while conventional laparoscopic surgery is effective
More informationHysterectomy. The time to take care of yourself
Hysterectomy The time to take care of yourself The time to take care of yourself Women spend a lot of time taking care of others spouses, children, parents. We often overlook our own needs. But when our
More informationHow To Compare The Effects Of A Hysterectomy And A Hysterectomy
A RANDOMIZED TRIAL COMPARING RADICAL HYSTERECTOMY AND PELVIC NODE DISSECTION VS SIMPLE HYSTERECTOMY AND PELVIC NODE DISSECTION IN PATIENTS WITH LOW RISK EARLY STAGE CERVICAL CANCER A Gynecologic Cancer
More informationPhysician. Patient HYSTERECTOMY HYSTERECTOMY. Treatment Options Risks and Benefits Experience and Skill
HYSTERECTOMY Physician Treatment Options Risks and Benefits Experience and Skill Patient Personal Preferences Values and Concerns Lifestyle Choices HYSTERECTOMY Shared Decision Making A process of open
More informationRESEARCH ARTICLE. Abstract. Introduction. Materials and Methods
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.13.5483 Perioperative and Oncologic Outcomes with Laparotomy, and Laparoscopic, and Robotic Surgery for Endometrial Cancer RESEARCH ARTICLE Comparison of Perioperative
More informationLaparoscopic Assisted Vaginal Hysterectomy
Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at ChiaYi 嘉 義 長 庚 紀 念 醫 院 婦 產 科 Clinical Guideline Laparoscopic Assisted Vaginal Hysterectomy By Dr. CJ Tseng Laparoscopic assisted
More informationSurgical Staging of Endometrial Cancer
Surgical Staging of Endometrial Cancer I. Endometrial Cancer Surgical Staging Overview Uterine cancer types: carcinomas type I and type II, sarcomas, carcinosarcomas Hysterectomy with BSO Surgical Staging
More informationDate: 06/06/2014 Our ref: 4496. I write in response to your request for information in relation to treatment for endometrial cancer in NHS Lothian.
Lothian NHS Board Waverley Gate 2-4 Waterloo Place Edinburgh EH1 3EG Telephone 0131 536 9000 Fax 0131 536 9088 www.nhslothian.scot.nhs.uk Date: 06/06/2014 Our ref: 4496 Enquiries to: Bryony Pillath Extension:
More informationRobotic versus total laparoscopic radical hysterectomy with pelvic lymphadenectomy for the treatment of early cervical cancer
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Goud JG et al. Int J Reprod Contracept Obstet Gynecol. 2014 Mar;3(1):34-39 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationSumma Health System. A Woman s Guide to Hysterectomy
Summa Health System A Woman s Guide to Hysterectomy Hysterectomy A hysterectomy is a surgical procedure to remove a woman s uterus (womb). The uterus is the organ which shelters and nourishes a baby during
More informationThe main surgical options for treating early stage cervical cancer are:
INFORMATION LEAFLET ON TOTAL LAPAROSCOPIC RADICAL HYSTERECTOMY (TLRH) FOR EARLY STAGE CERVICAL CANCER (TREATING EARLY STAGE CERVICAL CANCER BY RADICAL HYSTERECTOMY THROUGH KEYHOLE SURGERY) Aim of the leaflet
More informationUnderstanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE
Understanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE Introduction This guide is designed to help you clarify and understand the decisions that need to be made about your care for the
More informationGet the Facts, Be Informed, Make YOUR Best Decision. Pelvic Organ Prolapse
Pelvic Organ Prolapse ETHICON Women s Health & Urology, a division of ETHICON, INC., a Johnson & Johnson company, is dedicated to providing innovative solutions for common women s health problems and to
More informationConsidering a Hysterectomy?
Considering a Hysterectomy? Learn more about virtually scarless surgery using da Vinci Single-Site technology { {Symptoms & Conditions: Chronic Pain, Heavy Bleeding, Fibroids, Endometriosis, Adenomyosis,
More informationFacing Hysterectomy? Learn why da Vinci Surgery may be your best treatment option for early stage gynecologic cancer
Facing Hysterectomy? Learn why da Vinci Surgery may be your best treatment option for early stage gynecologic cancer The Condition: Early Stage Gynecologic Cancer A wide variety of gynecologic cancers
More informationSentinel Lymph Node Mapping for Endometrial Cancer. Locke Uppendahl, MD Grand Rounds
Sentinel Lymph Node Mapping for Endometrial Cancer Locke Uppendahl, MD Grand Rounds Endometrial Cancer Most common gynecologic malignancy in US estimated 52,630 new cases in 2014 estimated 8,590 deaths
More informationIs Total Laparoscopic Surgery for Endometrial Carcinoma at Risk of Local Recurrence? A Long-term Survival
Is Total Laparoscopic Surgery for Endometrial Carcinoma at Risk of Local Recurrence? A Long-term Survival RENATO SERACCHIOLI 1, STEFANO VENTUROLI 1, MICHELA CECCARINI 2, MARIANNA CANTARELLI 1, MARCELLO
More informationHysterectomy for womb cancer
Gynaecology Oncology Service Hysterectomy for womb cancer April 2014 Great Staff Great Care Great Future INTRODUCTION This leaflet has been produced to provide you with general information about your operation.
More informationConsidering Endometriosis Surgery? Learn about minimally invasive da Vinci Surgery
Considering Endometriosis Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Endometriosis Endometriosis is a condition in which the tissue that lines your uterus (the endometrium)
More informationIt has been almost 16 years since Childers et al 1,2
A Multiinstitutional Experience With Robotic-Assisted Hysterectomy With Staging for Endometrial Cancer M. Patrick Lowe, MD, Peter R. Johnson, MD, Scott A. Kamelle, MD, Saurabh Kumar, MD, Donald H. Chamberlain,
More informationHysterectomy. What is a hysterectomy? Why is hysterectomy done? Are there alternatives to hysterectomy?
ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM What is a hysterectomy? Hysterectomy Hysterectomy is
More informationAbout the Uterus. Hysterectomy may be done to treat conditions that affect the uterus. Some reasons a hysterectomy may be needed include:
Hysterectomy removal of the uterus is a way of treating problems that affect the uterus. Many conditions can be cured with hysterectomy. Because it is major surgery, your doctor may suggest trying other
More informationRADICAL HYSTERECTOMY IN ROBOTIC SURGERY
RADICAL HYSTERECTOMY IN ROBOTIC SURGERY FLORENCE BOCHU CENTRE OSCAR LAMBRET LILLE PATRICIA VARUMBEKE CENTRE OSCAR LAMBRET LILLE MELANIE FLAMENT CENTRE OSCAR LAMBRET LILLE More and more centers across the
More informationSafe and Effective Surgery for Endometriosis Including Detection and Intervention for Ovarian Cancer
Safe and Effective Surgery for Endometriosis Including Detection and Intervention for Ovarian Cancer Camran Nezhat,, MD, FACOG, FACS Stanford University Medical Center Center for Special Minimally Invasive
More informationLaparoscopic Hysterectomy
Laparoscopic Hysterectomy Department of Gynaecology Patient Information What is is a a laparoscopic hysterectomy? hysterectomy? A laparoscopic hysterectomy is an operation performed under general anaesthetic
More informationClinical Practice Assessment Robotic surgery
Clinical Practice Assessment Robotic surgery Background: Surgery is by nature invasive. Efforts have been made over time to reduce complications and the trauma inherently associated with surgery through
More informationINFORMED CONSENT FOR SLEEVE GASTRECTOMY
INFORMED CONSENT FOR SLEEVE GASTRECTOMY This informed-consent document has been prepared to help inform you about your Sleeve Gastrectomy including the risks and benefits, as well as alternative treatments.
More informationConsidering a Hysterectomy?
Considering a Hysterectomy? Learn more about virtually scarless surgery using da Vinci Single-Site technology { {Symptoms & Conditions: Chronic Pain, Heavy Bleeding, Fibroids, Endometriosis, Pelvic Prolapse
More informationPatient. Frequently Asked Questions. Transvaginal Surgical Mesh for Pelvic Organ Prolapse
Patient Frequently Asked Questions Transvaginal Surgical Mesh for Pelvic Organ Prolapse Frequently Asked Questions WHAT IS PELVIC ORGAN PROLAPSE AND HOW IS IT TREATED? Q: What is pelvic organ prolapse
More informationInformation for patients having Total Laparoscopic Hysterectomy (TLH)
1 TOTAL LAPAROSCOPIC HYSTERECTOMY LEAFLET (For patients, relatives and hospital personnel) Information for patients having Total Laparoscopic Hysterectomy (TLH) You have been given this information sheet
More informationKeyhole (Laparoscopic) Surgery
Patient Information leaflet Keyhole (Laparoscopic) Surgery Produced by: Department of Obstetrics & Gynaecology December 2002 Reviewed April 2010 1 What is keyhole (laparoscopic) surgery? Laparoscopic surgery
More informationLaparoscopic Repair of Incisional Hernia. Maria B. ALBUJA-CRUZ, MD University of Colorado Department of Surgery-Grand Rounds
Laparoscopic Repair of Incisional Hernia Maria B. ALBUJA-CRUZ, MD University of Colorado Department of Surgery-Grand Rounds Overview Definition Advantages of Laparoscopic Repair Disadvantages of Open Repair
More informationLaparoscopic Hysterectomy
Any further questions? Please contact the matron for Women s Health on 020 7288 5161 (answerphone) Monday - Thursday 9am - 5pm. For more information: Royal College of Obstetrics and Gynaecology Recovering
More informationWomen s Health Laparoscopy Information for patients
Women s Health Laparoscopy Information for patients This leaflet is for women who have been advised to have a laparoscopy. It outlines the common reasons doctors recommend this operation, what will happen
More informationReview Article Robot-Assisted Radical Hysterectomy for Cervical Cancer: Review of Surgical and Oncological Outcomes
International Scholarly Research Network ISRN Obstetrics and Gynecology Volume 2011, Article ID 872434, 6 pages doi:10.5402/2011/872434 Review Article Robot-Assisted Radical Hysterectomy for Cervical Cancer:
More informationWhat factors determine poor functional outcome following Total Knee Replacement (TKR)?
Specific Question: What factors determine poor functional outcome following Total Knee Replacement ()? Clinical bottom line All groups derived benefit from undergoing a, reviews suggests that the decision
More informationHow To Treat Cervical Cancer
Total Laparoscopic Radical Hysterectomy in Cervical Cancer K Jardon, B. Rabischong, M, Canis, R Botchorishvili, C. Pomel, A. Wattiez, J.L Pouly G. Le Bouedec, J.L Achard, J. Dauplat, Mage G Polyclinique
More informationSummary and general discussion
Chapter 7 Summary and general discussion Summary and general discussion In this thesis, treatment of vitamin K antagonist-associated bleed with prothrombin complex concentrate was addressed. In this we
More informationThe Use of Minimally Invasive Surgery for Endometrial Cancer
Alternative approaches to traditional laparotomy such as minimally invasive surgery can diminish procedure-related morbidity and expedite recovery for patients with endometrial cancer. Marguerite Bride.
More informationMINIMALLY INVASIVE SURGERY FOR WOMEN Back to Life. Faster.
MINIMALLY INVASIVE SURGERY FOR WOMEN Back to Life. Faster. Pictured above: UF gynecologists Sharon Byun, MD, Shireen Madani Sims, MD, and Michael Lukowski, MD, with the robotic surgery equipment. Make
More informationTotal Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy: Cohort Review of Patients With Uterine Neoplasia
SCIENTIFIC PAPER Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy: Cohort Review of Patients With Uterine Neoplasia Katherine A. O Hanlan, MD, Gloria Shining Huang, MD, Anne-Caroline
More informationNo Costly Hospital Stays. No Unsightly Incisions. Far Faster, Less Painful Recovery.
No Costly Hospital Stays. No Unsightly Incisions. Far Faster, Less Painful Recovery. No Costly Hospital Stays. No Unsightly Incisions. Far Faster, Less Painful Recovery. Welcome to the Georgia Advanced
More information9/26/14. Joel E. Rand, MPAS, PA-C DMU Luncheon May 1, 2014
Joel E. Rand, MPAS, PA-C DMU Luncheon May 1, 2014 No financial relationship or commercial interest in any of the technologies discussed Not supporting any non-fda off label uses of any product or service
More informationOvarian Cystectomy / Oophorectomy
Cystectomy and Ovarian Cysts Ovarian cysts are sacs filled with fluids or pockets located on or in an ovary. In some cases, these cysts need to be removed surgically. Types of Cysts Ovarian cysts are quite
More informationA potential treatment for your abnormal uterine bleeding
TRUCLEAR System A potential treatment for your abnormal uterine bleeding Do You Suffer from Abnormal Uterine Bleeding? What is a Hysteroscopy? What is the TRUCLEAR Procedure? What Happens Before Your
More informationHow To Treat A Uterine Sarcoma
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition 2001 Uterus: Uterine Sarcomas Jeffrey L. Stern, MD Uterine sarcomas
More informationLaparoscopy and Hysteroscopy
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Laparoscopy and Hysteroscopy A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of
More informationThe percentage of women 21-64 years of age who received one or more Pap tests to screen for cervical cancer.
Measure Name: Cervical Cancer Screen Owner: NCQA (CCS) Measure Code: CER Lab Data: Y Rule Description: General Criteria Summary The percentage of women 21-64 years of age who received one or more Pap tests
More informationda Vinci Myomectomy Changing the Experience of Surgery Are you a candidate for the latest treatment option for uterine fibroids?
da Vinci Myomectomy Changing the Experience of Surgery Are you a candidate for the latest treatment option for uterine fibroids? Your doctor may be able to offer you a new, minimally invasive surgical
More informationNHS. Surgical repair of vaginal wall prolapse using mesh. National Institute for Health and Clinical Excellence. 1 Guidance.
Issue date: June 2008 NHS National Institute for Health and Clinical Excellence Surgical repair of vaginal wall prolapse using mesh 1 Guidance 1.1 The evidence suggests that surgical repair of vaginal
More informationOnce a woman has had a hysterectomy, she will no longer have menstrual periods and cannot have a child. She no longer needs to use contraception.
Hysterectomy Summary Hysterectomy is the surgical removal of the womb (uterus), with or without the cervix. Hysterectomy is used to treat a number of conditions, including heavy or painful periods, fibroids
More informationda Vinci Hysterectomy Changing the Experience of Surgery Are you a candidate for a breakthrough approach to hysterectomy?
da Vinci Hysterectomy Changing the Experience of Surgery Are you a candidate for a breakthrough approach to hysterectomy? Your doctor may be able to offer you a new, minimally invasive surgical procedure.
More informationFrequently Asked Questions About Ovarian Cancer
Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues
More informationBirth after previous caesarean. What are my choices for birth after a caesarean delivery?
Birth after previous caesarean Information for you Published September 2008 What are my choices for birth after a caesarean delivery? More than one in five women (20%) in the UK currently give birth by
More informationWOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500. Endometriosis
Endometriosis WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 The lining of the uterus is called the endometrium. Sometimes, endometrial tissue grows elsewhere in the body. When this happens
More informationNursing Care of the Patient Receiving Brachytherapy for Gynecologic Cancer
Nursing Care of the Patient Receiving Brachytherapy for Gynecologic Cancer Una Randall, RN, BSN, OCN Dana Farber / Brigham and Women s Cancer Center Department of Radiation Oncology Una Randall is not
More informationLess Invasive is Best
Less Invasive is Best June 22, 2011 By OBGYN.net Staff [1] Laparoscopic hysterectomy (LH) is an optimum approach to the second most common surgical procedure in the United States. There are close to 600,000
More informationStudy Design Of Medical Research
Study Design Of Medical Research By Ahmed A.Shokeir, MD,PHD, FEBU Prof. Urology, Urology & Nephrology Center, Mansoura, Egypt Study Designs In Medical Research Topics Classification Case series studies
More informationLIVING DONATION. What You Need to Know. www.kidney.org
LIVING DONATION What You Need to Know www.kidney.org 2 NATIONAL KIDNEY FOUNDATION TABLE OF CONTENTS About Living Donation.... 4 The Evaluation Process.... 6 Surgery and Recovery.... 12 After Donation....
More informationWhy I don t recommend endometrial ablation
Why I don t recommend endometrial ablation Endometrial ablation is a major operative procedure that: o Is ineffective because, according to all research, 40% will ultimately still need a hysterectomy,
More informationLaparoscopic Pelvic Surgery for Endometrial Cancer
130 Laparoscopic Pelvic Surgery for Endometrial Cancer Eng-Hseon Tay Original Article Laparoscopic Pelvic Surgery for Endometrial Cancer Eng-Hseon Tay, 1 FRCOG (UK), MMed (O & G), DGO (RANZCOG) Abstract
More informationSterilisation for women and men: what you need to know
Sterilisation for women and men: what you need to know Published January 2004 by the RCOG Contents Page number Key points 1 About this information 2 What are tubal occlusion and vasectomy? 2 What do I
More informationQUT Digital Repository: http://eprints.qut.edu.au/
QUT Digital Repository: http://eprints.qut.edu.au/ This is the accepted version of this journal article. Published as: Janda, Monika and Gebski, Val and Brand, Alison and Hogg, Russell and Jobling, Thomas
More informationFEMALE ANATOMY. the Functions of the Female Organs
FEMALE ANATOMY the Functions of the Female Organs An educational video for every woman who is told she needs pelvic surgery, including exploratory surgery or removal of the uterus, fallopian tubes, or
More informationNovaSure: A Procedure for Heavy Menstrual Bleeding
NovaSure: A Procedure for Heavy Menstrual Bleeding The one-time, five-minute procedure Over a million women 1 have been treated with NovaSure. NovaSure Endometrial Ablation (EA) is the simple, one-time,
More informationGlossary of Methodologic Terms
Glossary of Methodologic Terms Before-After Trial: Investigation of therapeutic alternatives in which individuals of 1 period and under a single treatment are compared with individuals at a subsequent
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationConsidering Surgery for Fibroids? Learn about minimally invasive da Vinci Surgery
Considering Surgery for Fibroids? Learn about minimally invasive da Vinci Surgery The Condition: Uterine Fibroid (Fibroid Tumor) A uterine fibroid is a benign (non-cancerous) tumor that grows in the uterine
More informationWhy would you need a hysterectomy?
Why would you need a hysterectomy? Removal of the uterus is performed to prevent, alleviate, or treat pain, pressure, bleeding, or cancer. Each reason is described in detail in the following pages. Benign
More informationTreating heavy menstrual bleeding caused by fibroids or polyps
Treating heavy menstrual bleeding caused by fibroids or polyps With today s medical advances the outlook for successful treatment of fibroids and polyps has never been better. You don t have to live with
More informationUterus myomatosus. 10-May-15. Clinical presentation. Incidence. Causes? 3 out of 4 women. Growth rate vary. Most common solid pelvic tumor in women
Uterus myomatosus A.J. Henriquez March 14, 2015 Uterus myomatosus Definition, incidence, clinical presentation and diagnosis. New FIGO classification for uterine leiomyomas Brief description on treatment
More informationPartnership for Healthcare Payment Reform Total Knee Replacement Pilot Quality Report Quarter 1 Quarter 4, 2013
Partnership for Healthcare Payment Reform Total Knee Replacement Pilot Quality Report Quarter 1 Quarter 4, 2013 Introduction This report outlines the total knee replacement pilot quality results for care
More informationMetastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy
Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy Sarah Hutto,, MSIV Marc Underhill, M.D. January 27, 2009 Past History 45 yo female
More informationEndometrial cancer-carcinoma of the lining of the uterus-is the most common gynecologic
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4th Edition 2001 Uterus: Endometrial Carcinoma Jeffrey L. Stern, MD Endometrial
More informationSOGC Recommendations for Urinary Incontinence
The quality of evidence is rated, and recommendations are made using the criteria described by the Canadian Task Force on Preventive Health Care. Clinical Practice Guidelines: The Evaluation of Stress
More informationOriginal Article Clinical observation of laparoscopic radical hysterectomy for cervical cancer
Int J Clin Exp Med 2014;7(5):1373-1377 www.ijcem.com /ISSN:1940-5901/IJCEM0000304 Original Article Clinical observation of laparoscopic radical hysterectomy for cervical cancer Xiang-Hua Yin, Zhong-Qin
More informationA Guide to Hysteroscopy. Patient Education
A Guide to Hysteroscopy Patient Education QUESTIONS AND ANSWERS ABOUT HYSTEROSCOPY Your doctor has recommended that you have a procedure called a hysteroscopy. Naturally, you may have questions about
More informationStudy Design and Statistical Analysis
Study Design and Statistical Analysis Anny H Xiang, PhD Department of Preventive Medicine University of Southern California Outline Designing Clinical Research Studies Statistical Data Analysis Designing
More informationUnderstanding Endometriosis - Information Pack
What is endometriosis? Endometriosis (pronounced en- doh mee tree oh sis) is the name given to the condition where cells like the ones in the lining of the womb (uterus) are found elsewhere in the body.
More informationLaparoscopic Surgery for Endometrial Cancer: A Phenomenological Study of Patient Experience
Laparoscopic Surgery for Endometrial Cancer: A Phenomenological Study of Patient Experience Cathy Hughes Patient Safety Lead for Cancer National Patient Safety Agency Study Aim To describe women s perspectives
More informationBREAST CANCER RISK ASSESSMENT AND PRIMARY PREVENTION FOR HIGH RISK PATIENTS, RACHEL CATHERINE JANKOWITZ, MD 1
FOR HIGH RISK PATIENTS, RACHEL CATHERINE JANKOWITZ, MD 1 Hello, my name is Rachel Jankowitz, I m an assistant professor of medicine in the Division of Hematology Oncology at the University of Pittsburgh
More informationSchauta sine utero : technique and results of laparoscopic vaginal radical parametrectomy
Available online at www.sciencedirect.com R Gynecologic Oncology 91 (2003) 359 368 www.elsevier.com/locate/ygyno Schauta sine utero : technique and results of laparoscopic vaginal radical parametrectomy
More informationThe role of vaginal hysterectomy in the treatment of endometrial carcinoma
Int J Gynecol Cancer 1994, 4, 342-347 The role of vaginal hysterectomy in the treatment of endometrial carcinoma R. J. LELLI~*, G. W. MORLEY* & W. A. PETERS ~ *Department of Obstetrics and Gynecology,
More informationWeight Loss before Hernia Repair Surgery
Weight Loss before Hernia Repair Surgery What is an abdominal wall hernia? The abdomen (commonly called the belly) holds many of your internal organs. In the front, the abdomen is protected by a tough
More informationVAGINAL MESH FAQ. How do you decide who should get mesh as part of their repair?
VAGINAL MESH FAQ How do you decide who should get mesh as part of their repair? Each patient with pelvic organ prolapse (POP) is considered individually. In younger women, women with an uncomplicated prolapse
More informationPerioperative Outcomes in Robotic-Assisted Versus Conventional Laparoscopic Treatment of Endometrial Cancer
Research Article imedpub Journals http://www.imedpub.com/ Journal of Adenocarcinoma 206 Vol. No. :6 Perioperative Outcomes in Robotic-Assisted Versus Conventional Laparoscopic Treatment of Endometrial
More informationLAPAROSCOPIC OVARIAN CYSTECTOMY
LAPAROSCOPIC OVARIAN CYSTECTOMY Information Leaflet Your Health. Our Priority. Page 2 of 5 About this information This leaflet is for you if you have a cyst on one or both ovaries and are considering surgery.
More information